ArticlePeerJ2022

Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology.

Hongwen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.